Patent applications published 7 July 2010
Selected patent applications from the weekly European Patents Bulletin
- Synthesis of resveratrol-based natural products
The Trustees of Columbia University in the City of New York 2203049*
- Use of R-(+)-N-propargyl-1-aminoindan to treat or prevent hearing loss
Teva Pharmaceutical Industries 2203050*
- Octahydropentalene compounds as chemokine receptor antagonists
Abbott Laboratories 2203051*
- Modified starch material of biocompatible hemostasis
Starch Medical 2203053*
- Stabiliser concentrate for matrix compsns processed at elevated temperatures
Isp Investments 2203054*
- 1-methyl nicotinamide and derivatives for treatment of gastric injury
Cortria Corp 2203055*
- Controlled release pharmaceutical compsns
Mulye, Nirmal 2203056*
- Method and compsns for treatment or prevention of inflammatory conditions
University of Rochester 2203057*
- Methods and compounds for modulating cannabinoid activity
Northeastern University 2203058*
- Method of treating inherited severe neutropenia
Merck Sharp &_Dohme; University of Washington 2203059*
- Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase
Bayer Healthcare 2203060*
- Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
Jenrin Discovery 2203061*
- Methods of inhibiting viral infection
Functional Genetics 2203065*
- Compsns and methods using substances containing carbon
Calera Corp 2203067*
- Methods of treating gastrointestinal disorders independent of the intake of food
Takeda Pharmaceuticals North America 2203068*
- Treatment of pulmonary disorders with aerosolised medicaments such as vancomycin
Novartis 2203155*
- Candesartan cilexetil
Huahai Zheijiang Huahai Pharmaceutical; Alfred E_Tiefenbacher GmbH 2203156*
- Pharmaceutical formulation for extended release
AstraZeneca 2203157*
- Pharmaceutical formulations comprising telmisartan and hydrochlorothiazide
Dr Reddy’s Laboratories 2203158*
- Dispersion of poloxamer-protein particles, methods of manufacturing and uses thereof
Institut National de la Sante et de la Recherche Medicale (INSERM); Université d’Angers 2203159*
- Pharmacological adjunctive treatment associated with glaucoma filtration surgery
Bausch &_Lomb 2203160*
- Quinone derivatives, pharmaceutical compsns and uses thereof
Indiana University Research and Technology 2203161*
- Benzoquinone derivative E3330 in combination with chemotherapeutic agents for the treatment of cancer and angiogenesis
Indiana University Research and Technology Corp 2203162*
- Titration package for neramexane and its use in the treatment of inner ear disorder
Merz Pharma 2203163*
- Method and apparatus for diagnosis of hemangiosarcoma in mammals
Veterinary Diagnosis Institute; Colorado State University Research Foundation 2203164*
- Opthalmic formulation containing paracetamol
Stellenbosch University 2203165*
- Bilayer compsns for the sustained release of acetaminophen and tramadol
Labopharm; Labopharm Europe; Labopharm (Barbados) 2203166*
- Compound and use thereof in the treatment of amyloidosis
Pentraxin Therapeutics 2203167*
- Methods of treating a flaviviridae family viral infection and compsns for treating a flaviviridae family viral infection
Stanford University 2203168*
- Glycemic control, diabetes treatment and other treatments with acetyl cholinesterase inhibitors
Wills, Stephen 2203169*
- Novel therapeutic uses of adrenergic alpha-1 receptor antagonists
Sanofi-Aventis 2203170*
- CB2 receptor ligands for the treatment of pain
Merck Sharp &_Dohme 2203171*
- Use of V2 receptor antagonists in combination with vasopressinergic agonists
Ferring 2203172*
- Means and methods for counteracting muscle disorders
Academisch Ziekenhuis Leiden; Prosensa Technologies 2203173*
- Therapeutic regimens for the treatment of immunoinflammatory disorders
Combinatorx 2203174*
- Preparation of wound healing and prevention of bandage adhesion to the wound, containing chitosan-glucan
CPN_Spol SRO 2203175*
- Tumour suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
Celgene Cellular Therapeutics 2203176*
- Methods and kits for the treatment of diverticular conditions
Procter &_Gamble 2203177*
- Estrogenic extracts of Pueraria lobata willd, ohwi of the leguminosae family and uses thereof
Bionovo 2203178*
- Vancomycin and teicoplanin anhydrous formulations for topical use
Pharmatex Italia 2203179*
- Single IFN-beta fused to a mutated IGG_FC_fragment
Merck Serono 2203180*
- An orally administerable solid pharma-ceutical compsn and a process thereof
Biocon 2203181*
- Synthetic antigenic peptides and lipo-peptides derived from Mycobacterium avium subsp. paratuberculosis
Institut National de la Sante et de la Recherche Medicale, Institut National de la Recherche Agronomique; Institut Pasteur 2203182*
- Medicaments and methods for treating mesothelioma
Institut Pasteur 2203183* - Medicaments and methods for treating mesothelioma